Daewoong Pharmaceutical, Daewoong Bio, and Cutis Bio sign agreement for eco-friendly sustainable drug material development
Daewoong Pharmaceutical, Daewoong Bio, and Cutis Bio have signed an agreement to develop eco-friendly and sustainable drug materials. This collaboration aims to advance the pharmaceutical industry's environmental sustainability efforts.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.